Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer

Files in this item

This item appears in the following Collection(s)

Available in accordance with the IUPUI Open Access Policy.

Search Repository


My Account

Statistics